journal
https://read.qxmd.com/read/38759099/clinical-presentation-antimicrobial-resistance-and-treatment-outcomes-of-aeromonas-human-infections-a-14-year-retrospective-study-and-comparative-genomics-of-two-isolates-from-fatal-cases
#1
JOURNAL ARTICLE
Roberto Pineda-Reyes, Blake H Neil, Joseph Orndorff, Natalie Williams-Bouyer, Michael Netherland, Nur A Hasan, Md Ibrahim Tahashilder, Jian Sha, Ashok K Chopra, David Reynoso
BACKGROUND: Aeromonas virulence may not be entirely dependent on the host immune status. Pathophysiologic determinants of disease progression and severity remain unclear. METHODS: One hundred five patients with Aeromonas infections and 112 isolates were identified, their clinical presentations and outcomes analyzed, and their antimicrobial resistance (AMR) patterns assessed. Two isolates (A and B) from fatal cases of Aeromonas dhakensis bacteremia were characterized using whole genome sequence analysis...
May 17, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38758977/association-between-infectious-diseases-consultation-and-mortality-in-hospitalized-patients-with-gram-negative-bloodstream-infection-a-retrospective-population-wide-cohort-study
#2
JOURNAL ARTICLE
Sean W X Ong, Jin Luo, Daniel J Fridman, Samantha M Lee, Jennie Johnstone, Kevin L Schwartz, Christina Diong, Samir N Patel, Derek R MacFadden, Bradley J Langford, Steven Y C Tong, Kevin A Brown, Nick Daneman
OBJECTIVES: Data supporting routine infectious diseases (ID) consultation in Gram-negative bloodstream infection (GN-BSI) are limited. We evaluated the association between ID consultation and mortality in patients with GN-BSI in a retrospective population-wide cohort study in Ontario using linked health administrative databases. METHODS: Hospitalized adult patients with GN-BSI between April 2017 and December 2021 were included. The primary outcome was time to all-cause mortality censored at 30 days, analyzed using a mixed effects Cox proportional hazards model with hospital as a random effect...
May 17, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38757368/is-there-room-for-metformin-at-covid-19-s-dinner-table-updated-analysis-of-clinical-trials
#3
JOURNAL ARTICLE
Todd C Lee, David R Boulware
No abstract text is available yet for this article.
May 17, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38752732/breakthrough-invasive-fungal-infections-in-patients-with-high-risk-hematological-disorders-receiving-voriconazole-and-posaconazole-prophylaxis-a-systematic-review
#4
JOURNAL ARTICLE
Catherine-Audrey Boutin, Florence Durocher, Stéphanie Beauchemin, Daniela Ziegler, Claire Nour Abou Chakra, Simon Frédéric Dufresne
BACKGROUND: Primary antifungal prophylaxis with mold-active azoles is used to prevent invasive fungal infections in patients with high-risk hematological disorders; however, breakthrough infections occur, and the reasons for treatment failure are still not fully understood. To help inform clinical decisions, we sought to define microbiological, clinical, and pharmacological characteristics of proven and probable breakthrough invasive fungal infections (bIFIs) in patients with high-risk hematological disorders receiving voriconazole or posaconazole prophylaxis...
May 16, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38752395/the-obstacle-is-the-way-finding-a-path-to-hepatitis-c-elimination
#5
JOURNAL ARTICLE
Vincent Lo Re, Jennifer C Price, Steven Schmitt, Norah Terrault, Debika Bhattacharya, Andrew Arohnson
No abstract text is available yet for this article.
May 16, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38752311/impact-of-intrapartum-azithromycin-on-the-carriage-and-antibiotic-resistance-of-escherichia-coli-and-klebsiella-pneumoniae-in-mothers-and-their-newborns-a-sub-study-of-a-randomized-double-blind-trial-conducted-in-the-gambia-and-burkina-faso
#6
JOURNAL ARTICLE
Pauline Getanda, Isatou Jagne, Joel D Bognini, Bully Camara, Bakary Sanyang, Saffiatou Darboe, Ellen Sambou, Momodou Barry, Kady Kassibo, Aminata Cham, Harriet Mendy, Bintou K J Singateh, Ebrahim Ndure, Toussaint Rouamba, Abdoulie Bojang, Christian Bottomley, Benjamin P Howden, Umberto D'Alessandro, Halidou Tinto, Anna Roca
BACKGROUND: Limited data exists on effects of intrapartum azithromycin on prevalence of carriage and antibiotic resistance of Enterobacterales. METHODS: We conducted a randomized trial in Gambia and Burkina Faso where women received intrapartum azithromycin (2g) or placebo. We determined impact of treatment on prevalence of carriage and antibiotic resistance of Escherichia coli and Klebsiella pneumoniae by analysing rectal swabs (RS), nasopharyngeal swabs (NPS), breast milk and recto-vaginal swabs (RVS)...
May 16, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38748464/pharmaco-virological-outcomes-and-genotypic-resistance-profiles-among-children-and-adolescents-receiving-a-dtg-based-regimen-in-togo
#7
JOURNAL ARTICLE
Yao Rodion Konu, Elom Takassi, Gilles Peytavin, Nina Dapam, Florence Damond, Wone Adama Oumarou, Meryem Zaidi, Anna-Maria Franco-Yusti, Claver A Dagnra, Quentin Le Hingrat, Romain Coppée, Diane Descamps, Fatoumata Binta Tidiane Diallo, Didier K Ekouevi, Charlotte Charpentier
BACKGROUND: Few data are available on the real-world efficacy of receiving tenofovir-lamivudine-dolutegravir (DTG) as HIV treatment, particularly among young people in West Africa. Here, we evaluated pharmaco-virological outcomes and resistance profiles among Togolese children and adolescents. METHODS: A cross-sectional study was conducted in Lomé, Togo, enrolling antiretroviral-treated people with HIV aged from 18 months to 24 years. Plasma HIV-1 viral load and antiretroviral concentrations were measured...
May 15, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38748183/enhanced-tuberculosis-diagnosis-with-computer-aided-chest-x-ray-and-urine-lam-in-adults-with-hiv-admitted-to-hospital-castle-study-a-cluster-randomised-trial
#8
JOURNAL ARTICLE
Rachael M Burke, Saulos K Nyirenda, Timeo Mtenga, Hussein H Twabi, Elizabeth Joekes, Naomi F Walker, Rose Nyirenda, Ankur Gupta-Wright, Marriott Nliwasa, Katherine Fielding, Peter MacPherson, Elizabeth L Corbett
BACKGROUND: People with HIV (PHIV) admitted to hospital have high mortality, with tuberculosis (TB) being the major cause of death. Systematic use of new TB diagnostics could improve TB diagnosis and might improve outcomes. METHODS: We conducted a cluster randomised trial among adult PHIV admitted to Zomba Central Hospital, Malawi. Admission-days were randomly assigned to: enhanced TB diagnostics using urine lipoarabinomannan (LAM) antigen tests (SILVAMP-LAM, Fujifilm, Japan and Determine-LAM, Alere/Abbot, USA), digital chest X-ray with computer aided diagnosis (dCXR-CAD, CAD4TBv6, Delft, Netherlands), plus usual care ("enhanced TB diagnostics"); or usual care alone ("usual care")...
May 15, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38747695/doff-thy-gown-shedding-contact-precautions-for-covid-19
#9
JOURNAL ARTICLE
Alexander S Rabin, Linsey C Marr, Henry M Blumberg
SARS-CoV-2 is predominantly transmitted through aerosols (i.e., airborne transmission), however, the US Centers for Disease Control and Prevention continue to recommend the use of contact precautions (a gown and gloves) for the care of patients with COVID-19. Infection prevention guidelines should reflect the current science and eliminate this wasteful practice.
May 15, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38743581/quantifying-the-time-to-administer-outpatient-parenteral-antimicrobial-therapy-a-missed-opportunity-to-compensate-for-the-value-of-infectious-diseases
#10
JOURNAL ARTICLE
Asher J Schranz, Michael Swartwood, Madison Ponder, Renae Boerneke, Teresa Oosterwyk, Angela Perhac, Claire E Farel, Alan C Kinlaw
Outpatient parenteral antimicrobial therapy (OPAT) relies on substantial uncompensated provider time. In this study of a large academic OPAT program, the median amount of unbilled OPAT management time was 27 minutes per week, per OPAT course. These data should inform benchmarks in pursuing novel payment approaches for OPAT.
May 14, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38743579/influence-of-antibiotic-exposure-intensity-on-the-risk-of-clostridioides-difficile-infection
#11
JOURNAL ARTICLE
Michael J Ray, Luke C Strnad, Kendall J Tucker, Jon P Furuno, Eric T Lofgren, Caitlin M McCracken, Hiro Park, Jeffrey S Gerber, Jessina C McGregor
BACKGROUND: Antibiotics are a strong risk factor for Clostridioides difficile infection (CDI), and CDI incidence is often measured as an important outcome metric for antimicrobial stewardship interventions aiming to reduce antibiotic use. However, risk of CDI from antibiotics varies by agent and dependent on the intensity (i.e., spectrum and duration) of antibiotic therapy. Thus, the impact of stewardship interventions on CDI incidence is variable, and understanding this risk requires a more granular measure of intensity of therapy than traditionally used measures like days of therapy (DOT)...
May 14, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38743564/lowering-the-acquisition-of-multi-drug-resistant-organism-mdros-with-pulsed-xenon-lamp-study-a-cluster-randomized-controlled-double-blinded-interventional-crossover-trial
#12
JOURNAL ARTICLE
Sorabh Dhar, Chetan Jinadatha, Paul E Kilgore, Oryan Henig, George W Divine, Erika N Todter, John D Coppin, Marissa J Carter, Teena Chopra, Steve Egbert, Philip C Carling, Keith S Kaye
BACKGROUND: Environmental disinfection is essential for reducing spread of healthcare associated infections (HAIs). Previous studies report conflicting results regarding the effects of ultraviolet light (UV) in reducing infections. This trial evaluated the impact of adding pulsed xenon UV (PX-UV) to standard terminal cleaning in reducing environmentally-implicated HAIs (eiHAIs). METHODS: The LAMP trial was conducted in 2 hospitals (15 inpatient wards) utilizing a cluster randomized controlled, double-blinded, interventional crossover trial comparing standard terminal cleaning followed by either pulsed xenon ultraviolet (PX-UV) disinfection (intervention arm) or sham disinfection (control arm)...
May 14, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38742848/the-value-of-outpatient-parenteral-antimicrobial-therapy-better-care-in-twenty-seven-minutes
#13
JOURNAL ARTICLE
Addison S Hicks, Joshua C Eby
No abstract text is available yet for this article.
May 14, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38742844/high-prevalence-of-unconfirmed-positive-hiv-pcr-test-results-among-african-infants-with-hiv-exposure-in-the-international-epidemiology-databases-to-evaluate-aids-iedea-consortium
#14
JOURNAL ARTICLE
James G Carlucci, Thomas Huntington, Karl-Günter Technau, Marcel Yotebieng, Valériane Leroy, Kim Anderson, Madeleine Amorissani-Folquet, Kara Wools-Kaloustian, Andrew Edmonds
In a large, multi-regional cohort of African infants with HIV exposure, 44% of those with a positive HIV PCR lacked a confirmatory positive test. Efforts are needed to ensure high-fidelity implementation of HIV testing algorithms, so that all positive results are confirmed thereby reducing the risk of potentially false-positive results.
May 14, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38739755/effectiveness-of-double-dose-dolutegravir-in-people-receiving-rifampin-based-tuberculosis-treatment-an-observational-cohort-study-of-people-with-hiv-from-six-countries
#15
JOURNAL ARTICLE
N Sarita Shah, Cissy Kityo, Michael D Hughes, Caitlyn McCarthy, Carole Wallis, Mina Hosseinipour, Deborah Langat, Mulinda Nyirenda, Mohammed Rassool, Rodney Dawson, Yvetot Joseph, Fatma Some, Rosie Mngqbisa, Pamela Grace Mukwekwerere, Elizabeth Woolley, Catherine Godfrey, Yukari C Manabe, John W Mellors, Charles Flexner, Gary Maartens
BACKGROUND: Tenofovir-lamivudine-dolutegravir (TLD) is the preferred first-line antiretroviral therapy (ART) regimen. An additional 50 mg dose of dolutegravir (TLD + 50) is required with rifampin-containing tuberculosis (TB) co-treatment. There are limited data on the effectiveness of TLD + 50 in individuals with TB/HIV. METHODS: Prospective, observational cohort study at 12 sites in Haiti, Kenya, Malawi, South Africa, Uganda, Zimbabwe...
May 13, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38739754/assessment-of-spillover-of-antimicrobial-resistance-to-untreated-children-7-to-12-years-old-after-mass-drug-administration-of-azithromycin-for-child-survival-in-niger-a-secondary-analysis-of-the-mordor-cluster-randomized-trial
#16
JOURNAL ARTICLE
Brittany Peterson, Ahmed M Arzika, Abdou Amza, Ramatou Maliki, Alio Mankara Karamba, Mariama Moussa, Mariama Kemago, Zijun Liu, Eric Houpt, Jie Liu, Suporn Pholwat, Thuy Doan, Travis Porco, Jeremy D Keenan, Thomas M Lietman, Kieran S O'Brien
BACKGROUND: The risk of antibiotic resistance is complicated by the potential for spillover effects from one treated population to another. Azithromycin mass drug administration programs report higher rates of antibiotic resistance among treatment arms in targeted groups. This study aims to understand the risk of spillover of antibiotic resistance to non-target groups in these programs. METHODS: Data was used from a cluster-randomized trial comparing the effect of biannual azithromycin and placebo distribution to children 1-59 months on child mortality...
May 13, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38738642/more-high-quality-evidence-curbing-our-enthusiasm-for-enhanced-terminal-decontamination-of-hospital-rooms-with-no-touch-technologies-is-it-lights-out-for-uv-c
#17
JOURNAL ARTICLE
Michihiko Goto, Curtis J Donskey
No abstract text is available yet for this article.
May 13, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38735657/anti-spike-monoclonal-antibody-monotherapies-and-immune-escape-risk-minimization-strategies
#18
JOURNAL ARTICLE
Arturo Casadevall, Daniele Focosi
No abstract text is available yet for this article.
May 13, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38735656/a-review-of-local-practice-for-histoplasma-testing-in-a-uk-referral-centre-for-imported-infections
#19
JOURNAL ARTICLE
Isabella Watts, Hamish Houston, Rebecca Gorton, Neil Stone
No abstract text is available yet for this article.
May 12, 2024: Clinical Infectious Diseases
https://read.qxmd.com/read/38734971/social-factors-associated-with-congenital-syphilis-in-missouri
#20
JOURNAL ARTICLE
Elizabeth Daniels, Andrew Atkinson, Nicholas Cardoza, Aditi Ramakrishnan, Denise Willers, Hilary Reno
BACKGROUND: Congenital syphilis disproportionately affects individuals impacted by adverse social determinants of health. Understanding these determinants may help facilitate holistic care. METHODS: We performed a retrospective review of mother-infant dyads with potential congenital syphilis in a Missouri hospital system. Cases were classified per Centers for Disease Control and Prevention clinical scenarios. Information was collected regarding demographics, prenatal care, substance use, and other social factors...
May 12, 2024: Clinical Infectious Diseases
journal
journal
20074
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.